[1]桂志兵,汪文生.红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用[J].医学信息,2018,31(20):65-68.[doi:10.3969/j.issn.1006-1959.2018.20.019]
　GUI Zhi-bing,WANG Wen-sheng.The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis[J].Medical Information,2018,31(20):65-68.[doi:10.3969/j.issn.1006-1959.2018.20.019]
点击复制

红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年20期
页码:
65-68
栏目:
论著
出版日期:
2018-10-15

文章信息/Info

Title:
The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis
文章编号:
1006-1959（2018）20-0065-04
作者:
桂志兵; 汪文生
安徽医科大学附属安庆医院消化内科，安徽 安庆 246000
Author(s):
GUI Zhi-bing; WANG Wen-sheng
Department of Gastroenterology,Anqing Hospital,Anhui Medical University,Anqing 246000,Anhui,China
关键词:
乙型肝炎; 肝硬化; 红细胞分布宽度与血小板计数比值; Child-Pugh分级; 终末期肝病模型
Keywords:
epatitis B; Liver cirrhosis; Red blood cell distribution width and platelet ratio; Child-Pugh classification; End-stage liver disease model
分类号:
R575
DOI:
10.3969/j.issn.1006-1959.2018.20.019
文献标志码:
A
摘要:
目的 探讨红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者诊断及预后评估的关系。方法 选择2013年1月~2015年12月我院诊断为乙型肝炎肝硬化的患者144例、慢性乙型肝炎患者80例及同期健康体检者80例作为研究对象，收集其住院和（或）门诊检查资料，记录一般实验室检查结果，如血RDW、PLT、ALT、AST，计算基于血清学指标的模型，即RPR、APRI、FIB-4、Child-Pugh评分。相关性分析采用Spearman相关分析，绘制ROC曲线、计算AUC来判断RPR对肝硬化的预测价值。运用Kaplan-Meier法分析高RPR组与低RPR组乙型肝炎肝硬化患者3年生存率，同时将RPR、Child-Pugh评分纳入Cox回归分析，绘制54例乙型肝炎肝硬化死亡患者ROC曲线，判断RPR对乙型肝炎肝硬化患者预后的预测价值。结果 乙肝组、肝硬化组RPR分别为（0.33±0.16）Fl/(109/L）、（1.24±1.55）Fl/(109/L），均高于健康体检组的（0.24±0.05）Fl/(109/L），统计学意义显著(P＜0.01)；肝硬化组RPR高于乙肝组，统计学意义显著（P＜0.01）。RPR与乙型肝炎肝硬化呈正相关（r=0.66，P＜0.01）。RPR预测乙型肝炎肝硬化的AUC为0.91，优于APRI，次于FIB-4，差异有统计学意义（P＜0.05）。RPR、FIB-4、APRI诊断乙型肝炎肝硬化的最佳界值分别为0.43、3.00和0.79（P＜0.01），敏感度分别为84.00%、82.60%、84.00%，特异度分别为90.00%、95.00%和76.20%。RPR与Child-Pugh评分及MELD均呈正相关，r值分别为0.35、0.34（P＜0.01）。高RPR组和低RPR组在随访3年期间生存率分别为56.80%和68.60%，差异无统计学意义（P＞0.05）。结论 RPR可用于乙型肝炎肝硬化的诊断，RPR预测乙型肝炎肝硬化患者死亡的敏感性好，但特异性差，联合RPR可提高CP评分对乙肝肝硬化患者的预后评估效果。
Abstract:
Objective To investigate the relationship between red blood cell distribution width and platelet ratio in the diagnosis and prognosis evaluation of patients with hepatitis B cirrhosis.Methods From January 2013 to December 2015,144 patients with hepatitis B cirrhosis diagnosed in our hospital,80 patients with chronic hepatitis B and 80 healthy patients with physical examination were enrolled as study subjects,collect hospitalization and/or outpatient examination data,record general laboratory findings such as blood RDW,PLT,ALT,AST,and calculate models based on serological indicators,such as RPR,APRI,FIB-4,Child-Pugh scores.Correlation analysis using Spearman correlation analysis,drawing ROC curve,calculating AUC to judge the predictive value of RPR for cirrhosis. The Kaplan-Meier method was used to analyze the 3-year survival rate of patients with hepatitis B cirrhosis in the high RPR group and the low RPR group.The RPR and Child-Pugh scores were included in the Cox regression analysis to map the ROC curves of 54 patients with hepatitis B cirrhosis.To predict the predictive value of RPR for the prognosis of patients with hepatitis B cirrhosis. Results The RPR of the hepatitis B group and the cirrhosis group were(0.33±0.16)Fl/(109/L)and(1.24±1.55)Fl/(109/L),respectively, which were higher than that of the healthy examination group(0.24±0.05)Fl/(109/L),the difference was statistically significant(P<0.01); the RPR of the cirrhosis group was higher than that of the hepatitis B group,the difference was statistically significant(P<0.01).RPR was positively correlated with hepatitis B cirrhosis(r=0.66,P<0.01).RPR predicts an AUC of 0.91 for hepatitis B cirrhosis,which is superior to APRI,which is second to FIB-4,the difference is statistically significant(P<0.05).The best cutoff values of RPR,FIB-4,and APRI for diagnosis of hepatitis B cirrhosis were 0.43,3.00,and 0.79,respectively(P<0.01),and the sensitivity was 84.00%,82.60%,and 84.00%,respectively,and the specificity was 90.00%,95.00% and 76.20%.RPR was positively correlated with Child-Pugh score and MELD,and the r values were 0.35 and 0.34, respectively(P<0.01).The survival rates of the high RPR group and the low RPR group were 56.80% and 68.60%,respectively,during the 3-year follow-up period,the difference was not statistically significant(P>0.05).Conclusion RPR can be used for the diagnosis of hepatitis B cirrhosis.RPR predicts the sensitivity of death in patients with hepatitis B cirrhosis,but the specificity is poor.Combined with RPR can improve the prognosis of CP patients with hepatitis B cirrhosis.

参考文献/References:

[1]Chen B,Ye B,Zhang J,et al.RDW to platelet ratio:a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B[J].PloS one,2013,8(7):e68780. [2]Pusuroglu H,Cakmak HA,Akgul O,et al.The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Rev Port Cardiol,2015,34(10):597-606. [3]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版)[J].中华肝脏病杂志,2015,23(12):888-905. [4]Wai CT,Greenson JK,Fontana RJ,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-526. [5]Sterling RK,Lissen E,Clumeck N,et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology,2006,43(6):1317-1325. [6]Wiesner R,Lake JR,Freeman RB.Model for end-stage liver disease(MELD)exception guidelines[J].Liver transplantation,2006,12(12 Suppl 3):S85-S87. [7]科技部十二五重大专项联合课题组.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华肝脏病杂志,2014,22(5):327-335. [8]Branchi F,Conti CB,Baccarin A,et al.Non-invasive assessment of liver fibrosis in chronic hepatitis B[J].World journal of gastroenterology,2014,20(40):14568-14580. [9]Wang H,Xu H,Qu L,et al.Red blood cell distribution width and globulin,noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients[J].European journal of gastroenterology&hepatology,2016,28(9):997-1002. [10]Wang J,Yan X,Yang Y,et al.A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B[J].Oncotarget,2017,8(35):59257- 59267. [11]Kim MY,Kang SH,et al.The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection[J].British journal of biomedical science,2018,75(3):128-132. [12]Kai Y,Zishu G,Shihe G,et al.Changes in Red Blood Cell Distribution Width is Associated with Liver Function Parameters and Prognosis in Patients with Chronic HBV Liver Disease[J].Clinical laboratory,2016,62(11):2197-2202. [13]Lassale C,Curtis A,Abete I,et al.Elements of the complete blood count associated with cardiovascular disease incidence: Findings from the EPIC-NL cohort study[J].Sci Rep,2018,8(1):3290. [14]Salvagno GL,Sanchis-Gomar F,Picanza A.Red blood cell distribution width:A simple parameter with multiple clinical applications[J].Critical reviews in clinical laboratory sciences,2015, 52(2):86-105. [15]Gangireddy VG,Kanneganti PC,Sridhar S,et al.Management of thrombocytopenia in advanced liver disease[J].Canadian journal of gastroenterology&hepatology,2014,28(10):558-564. [16]Wang X,Jiang W,Li F,et al.Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease[J].Liver international:official journal of the International Association for the Study of the Liver,2014,34(4):535-543. [17]Xu XY,Kong H,Song RX,et al.The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis:a systematic review and meta-analysis of diagnostic test accuracy[J].PloS one,2014,9(6):e100182.

相似文献/References:

[1]崔 洁.凝血酶原时间与血小板检验方式对诊断肝硬化疾病的临床价值研究[J].医学信息,2018,31(04):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
　CUI Jie.Study on the Clinical Value of Prothrombin Time and Platelet Examination in the Diagnosis of Liver Cirrhosis[J].Medical Information,2018,31(20):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
[2]祁兴顺,周新苗,许向波,等.肝硬化患者应用特利加压素治疗期间发生 低钠血症的现状研究[J].医学信息,2018,31(09):1.[doi:10.3969/j.issn.1006-1959.2018.09.001]
[3]王媛媛.乙型肝炎患者血清免疫球蛋白检测的意义[J].医学信息,2018,31(18):155.[doi:10.3969/j.issn.1006-1959.2018.18.050]
　WANG Yuan-yuan.Significance of Detection of Serum Immunoglobulin in Patients with Hepatitis B[J].Medical Information,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.18.050]
[4]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Medical Information,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
[5]李安乐,戴 夫,彭 琼.中性粒细胞与淋巴细胞比值、红细胞体积分布宽度与乙型肝炎及乙型肝炎肝硬化的关系研究[J].医学信息,2019,32(03):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
　LI An-le,DAI Fu,PENG Qiong.Relationship between Neutrophil-lymphocyte Ratio,Red Blood Cell Volume Distribution Width and Hepatitis B and Hepatitis B Cirrhosis[J].Medical Information,2019,32(20):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
[6]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Medical Information,2019,32(20):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[7]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(20):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[8]洪 亮,陶 静,张 静,等.上海市男性同性恋HIV感染者中乙型肝炎、丙型肝炎病毒的合并感染情况横断面研究[J].医学信息,2019,32(06):145.[doi:10.3969/j.issn.1006-1959.2019.06.046]
　HONG Liang,TAO Jing,ZHANG Jing,et al.Cross-sectional Study on the Co-infection of Hepatitis B and Hepatitis C Virus among HIV-infected People in Shanghai[J].Medical Information,2019,32(20):145.[doi:10.3969/j.issn.1006-1959.2019.06.046]
[9]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(20):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[10]裴金仙,陈天狮,任巧晶,等.IL-23在慢性乙型肝炎免疫调节中的作用研究[J].医学信息,2019,32(08):129.[doi:10.3969/j.issn.1006-1959.2019.08.037]
　PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Role of IL-23 in the Immune Regulation of Chronic Hepatitis B[J].Medical Information,2019,32(20):129.[doi:10.3969/j.issn.1006-1959.2019.08.037]

更新日期/Last Update: 2018-11-09